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Abstract 
Primary mesothelioma of the pericardium is a rare tumor and carries a dismal prognosis. 
This case report presents a 38-year-old man who suffered from recurrent pericardial fluid. 
Initial symptoms were unspecific, with dry cough and progressing fatigue. 
Pericardiocentesis was performed, but analyses for malignant cells and tuberculosis were 
negative. After recurrence a pericardiectomy was planned. At operation, partial resection 
of tumor tissue surrounding the heart was performed. Histopathologic examination 
including immunohistochemical staining for calretinin showed a biphasic mesothelioma. 
During the postoperative period the patient’s condition ameliorated, but symptoms 
recurred and the patient died 3 months after diagnosis and 15 months after the first 
symptoms. At autopsy, the pericardium was transformed by the tumor that also 
expanded into the mediastinum and had set metastases to the liver. A review of 29 cases 
presented in the recent literature indicates a higher incidence of malignant pericardial 
mesothelioma among men than women. Median age was 46 (range, 19–76) years. In 
pleural mesotheliomas, exposure to asbestos is a known risk factor. However, in primary 
pericardial mesotheliomas the evidence for asbestos as an etiologic factor seems to be 
less convincing (3 exposed among 14 cases). Symptoms are often unspecific and 
cytologic examination of pericardial fluid is seldom conclusive (malignant cells 
demonstrated in 4/17 cases). Partial resection of the tumor can give a period of symptom 
reduction. Only a few patients have been treated with chemotherapy. Median survival of 
patients with pericardial mesotheliomas is approximately 6 months. 
 
Introduction 
Malignant diseases of the pericardium can be divided into primary and secondary 
tumors. Secondary tumors are more frequent, and in this group, metastases from lung or 
breast cancer are most common [1].  
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Malignant mesotheliomas are rare tumors [2] that can occur in any of the body cavities 
covered by mesothelium. They arise most frequently in pleura but also in peritoneum, 
pericardium or tunica vaginalis testis. In a large review of 4,710 cases by Hillerdal 1982 
[3], pericardial mesotheliomas account for 0.7% of all malignant mesotheliomas. Our 
report presents one patient with pericardial mesothelioma and a review of 29 cases that 
appeared in English literature from 1993 through 2008. 
Case Report 
A 38-year-old metal worker, originally from Cyprus, was admitted to our clinic in October 2002 after 
over a year’s history of recurring pericardial fluid, followed by pericardiectomy and a tumour diagnosis. 
In November 2001, he was admitted to a local hospital due to cardiac tamponade. At that time he 
had a history of several weeks of dry cough and progressing fatigue. Pericardiocentesis with pericardial 
drain was performed. The fluid was clear and all analyses showed normal results, cultivations and PCR 
for tuberculosis were negative and cytological analysis of the fluid showed no malignant cells and only a 
small increase of eosinophilic cells. Chest X-ray was normal except for an increased heart volume; CT 
scan of the chest/abdomen showed pericardial fluid with a largest width of 4 cm, some amount of 
pleural fluid and some ascites (fig. 1). The radiological examination was interpreted as exudative 
pericarditis. A rheumatologist was consulted but could not find any explanation for the patient’s 
condition. Even a small genealogy was made, taking Mediterranean fever into consideration, but with 
negative results. It finally became clear that the patient had had a bicycle accident 3 weeks prior to the 
first symptoms from which he had suffered a haematoma in the thoracic wall. Because of this the 
plausible diagnosis was post-cardiac trauma syndrome. Standard treatment with cortisone was initiated 
and the symptoms as well as the pericardial fluid disappeared. During the next 6 months the patient had 
3 relapses, and in September 2002 he was referred to the University Hospital of Umeå for a 
pericardiectomy. At surgery, a thickened pericardium was opened and 1 l of filthy and hemorrhagic 
fluid was exploited. The heart was covered with a 0.5-cm thick layer that gave a constrictive 
hemodynamic. The layer was to some extent removed, but the area around the phrenic nerve was saved. 
The histopathologic examination showed biphasic mesothelioma of the pericardium with positive 
immunohistochemical staining for calretinin (fig. 2). After surgery, the patient’s symptoms diminished 
and in October 2002 he had recovered. At this time there was no indication for further postoperative 
treatment. One month later a follow-up CT scan showed pericardial fluid. The patient still had no 
symptoms. In the beginning of January 2003, his condition worsened with severe dyspnoea and he was 
admitted to the local hospital. Pleural fluid was stated and he was treated with corticosteroids and 
diuretics. Ten days later he was transported to our clinic for assessment of further treatment. However, 
his condition deteriorated and he died 3 months after diagnosis and 15 months after the first symptoms. 
Autopsy revealed an advanced tumour that embraced the heart. The pericardium was highly 
transformed by the neoplasm, thus whitish and solid with a thickness of 3–4 cm in large areas. The 
myocardium was partly invaded by the tumour and the delimitation between the pericardium and the 
myocardium was vague. The tumour also expanded from the pericardium to the central parts of the 
mediastinum. Muddy fluid was noted around the heart. Metastatic tumour growth was found in the 
liver. A small focus of papillary thyroid cancer with spread to local lymph nodes was also found at 
autopsy. 
Discussion and Literature Review 
In 1994, Thomason et al. [4] presented a case report and reviewed 27 cases of primary 
pericardial mesothelioma that appeared in English literature from 1972 to 1992. After this 
no extent review has been made. Our review includes 29 cases in English literature from 
1993 through 2008 where the diagnosis of primary pericardial mesothelioma was 
established [5–29]. It also includes the findings from our patient and the review, 
presented in table 1 and table 2. To provide an overview and comparison, the results 
from Thomason et al. [4] are presented adjacent to our data.  
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Table 1 illustrates that for 30 cases there is a male-female ratio of 3:1. The male 
domination correlates well with the review by Thomason et al. that reported a male 
dominance [4]. Andersen et al. [30] reported an even distribution between men and 
women. On the other hand, they used strict criteria for establishing the diagnosis primary 
pericardial mesothelioma which excluded cases with distant metastases and is thus not 
ideal for comparison. The youngest patient in this review was 19 years old and the eldest 
76 years old; there is an even distribution of the age range with a median age of 46 years. 
This corresponds to the review by Thomason et al. in which over half of the patients were 
diagnosed between the 5th and the 7th decade [4]. An illustration of the age range on the 
basis of gender shows an even distribution of men and women. No similar illustration is 
presented in the study by Thomason et al. [4]. 
No obvious relationship between asbestos exposure and the development of pericardial 
mesothelioma has been established. Table 1 illustrates asbestos exposure. Three cases with 
known exposure to asbestos are reported [5–7]. For 11 of the patients no known exposure 
to asbestos is reported [8–16]. Most of the reviewed articles do not contain any 
information about asbestos exposure. Thomason et al. reported that a third of the patients 
were exposed to asbestos [4]. 
The histological pattern of pericardial mesothelioma is classified into 3 categories 
according to the World Health Organization: predominantly epithelial, predominantly 
fibrous (spindle cell) and biphasic (mixed) [31]. Table 2 summarizes the pathologic 
findings of the patients in this review. The histological pattern was reported in 24 patients 
and revealed about the same distribution of epithelial and biphasic pattern, 13 and 7 
cases, respectively, while the fibrous or sarcomatoid pattern was rarer with only 4 cases. 
This result is similar to that of the study by Thomason et al., where the distribution was 
somewhat more even [4]. In the attempt to establish a diagnosis in these patients, 
cytological study of pericardial effusion is often made. Seventeen cases reported 
cytological findings from the effusion of pericardial fluid and only 24% of the cases 
presented malignant cells. The same result was demonstrated by Thomason et al. (20%) 
and this suggests cytological evaluation to be a poor method for the detection of 
mesothelioma [4]. 
The metastatic spread of mesothelioma is presented in table 2. According to Karadzic 
et al. [17], metastases are present in about 25–45% of the patients and involve regional 
lymph nodes, lungs and kidneys. Eren et al. [32] report a similar incidence of metastatic 
spread. In our study, 16 of the case reports contained information about metastatic 
spread, and 6 of them had no metastatic spread, 8 had regional lymph node involvement, 
2 had liver metastases and 1 patient had lung metastases. 
Survival distribution of the patients from the time when the first symptoms appeared is 
illustrated in fig. 3. Three patients were alive when the article was published [18], and for 
2 patients no information on survival was presented [19]. The median survival time from 
first symptoms in this review is 6 months. This dismal prognosis correlates with earlier 
studies; Cohen [31] showed average disease duration of approximately 5 months. No 
similar diagram was presented in the study by Thomason et al. [4]. 
In summary, this review of the clinical characteristics of patients with primary 
pericardial mesothelioma shows that initial symptoms are unspecific. Whether exposure 
to asbestos is related to the disease or not is uncertain. Treatment options are limited and 
the prognosis is dismal.  
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Table 1. Clinical material, gender, age and asbestos exposure 
 n  %  Thomason  et 
al. [4], % 
Gender      
Men 22  0.73 71 
Women  08  0.27 29 
Exposure to asbestos       
Exposure  03/14  0.21 33 
No known exposure  11/14  0.79 67 
Not mentioned  16/30  0.53 57 
  n  Median (min.–max.)  Thomason et 
al. [4] 
Age, years       
Men 22  45.5  (19–70)   
Women  08 52.5  (31–76)   
All 30  0.46 (19–76)  48 (12–77) 
 
 
Table 2. Histopathologic and metastatic findings 
 n  %  Thomason  et 
al. [4], % 
Mesothelioma type       
Biphasic  07/24 29  35 
Epithelial 13/24  54  35 
Sarcomatous  04/24 17  30 
Not available  06/30 20  28 
Effusion cytologic findings       
Benign 10/17  59  70 
Malignant  04/17 23  20 
No fluid available  03/17 18  0– 
Inconclusive  0–  0– 10 
Not available  13/30  43  64 
Metastases      
Lymphatic  08/16 50   
Hepatic  02/16 13   
None observed  06/16  38  
Not mentioned  14/30  47  
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Fig. 1. CT-scan of the thorax of the 38-year-old patient at presentation of symptoms. 
 
 
 
Fig. 2. Immunohistochemical staining for calretinin (Zymed, polyclonal rabbit anti-calretinin 
antibody, Invitrogen, Carlsbad, Calif., USA) showing a biphasic mesothelioma (20X). 
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Fig. 3. Kaplan-Meier plot of disease-specific survival of 30 patients with pericardial mesothelioma  
[5–29]. 
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